Thyrocare Technologies Ltd
NSE: THYROCARE BSE: 539871
₹495.50
+12.60 (2.61%)
Sun, 08 Nov 2026, 05:54 am
Market Cap (in Cr)7678.93
PE Ratio55.42
Dividend1.93
Health Services
Medical/Nursing Services
24.5KThyrocare Technologies Financials
| Particulars | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 760.65M | 1.07B | 1.31B | 1.46B | 1.75B | 2.31B | 3.04B | 3.56B | 4.03B | 4.34B | 4.95B | 5.89B | 5.27B | 5.72B | 6.87B |
| Gross profit | 425.86M | 578.25M | 694.86M | 742.95M | 736.78M | 988.01M | 1.47B | 1.80B | 1.92B | 1.95B | 1.91B | 2.65B | 1.50B | 1.81B | 2.27B |
| Operating expenses (excl. COGS) | -98.85M | -133.02M | -127.50M | -155.14M | -219.99M | -294.96M | -475.31M | -517.60M | -626.50M | -494.30M | -451.50M | -601.50M | -638.80M | -849.70M | -891.30M |
| Selling/general/admin expenses, total | -97.86M | -128.99M | -121.94M | -146.63M | -198.28M | -274.86M | -440.53M | -504.17M | -595.10M | -484.30M | -430.00M | -586.50M | -627.10M | -835.80M | -877.80M |
| Research & development | — | — | — | — | — | -1.50M | — | — | — | — | — | — | — | — | 0 |
| Selling/general/admin expenses, other | -97.86M | -128.99M | -121.94M | -146.63M | -198.28M | -273.36M | -440.53M | -504.17M | -595.10M | -484.30M | -430.00M | -586.50M | -627.10M | -835.80M | -877.80M |
| Other operating expenses, total | -990.00K | -4.03M | -5.56M | -8.51M | -21.71M | -20.10M | -34.78M | -13.43M | -31.40M | -10.00M | -21.50M | -15.00M | -11.70M | -13.90M | -13.50M |
| Operating income | 327.01M | 445.23M | 567.36M | 587.81M | 516.79M | 693.05M | 998.98M | 1.28B | 1.29B | 1.46B | 1.46B | 2.04B | 865.50M | 958.40M | 1.38B |
| Non-operating income, total | 49.26M | 74.90M | 211.38M | 101.14M | 148.60M | 124.98M | -182.24M | 170.00M | 89.70M | -58.50M | 69.50M | 234.80M | 8.60M | -2.50M | 85.50M |
| Interest expense, net of interest capitalized | -660.00K | -720.00K | -970.00K | -1.60M | -3.00M | -5.51M | -1.95M | -3.49M | -6.10M | -18.50M | -8.70M | -23.70M | -48.30M | -55.30M | -37.60M |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 49.92M | 75.62M | 212.35M | 102.74M | 155.67M | 162.59M | 90.49M | 166.04M | 95.20M | 25.80M | 78.20M | 258.50M | 56.90M | 52.80M | 122.90M |
| Non-operating interest income | 18.44M | 44.24M | 37.83M | 6.98M | 3.40M | 280.00K | 2.04M | 2.23M | 6.00M | 7.00M | 7.70M | 6.90M | 9.00M | 26.90M | 22.10M |
| Miscellaneous non-operating expense | 31.48M | 31.38M | 174.52M | 95.76M | 152.27M | 162.31M | 88.45M | 163.81M | 82.60M | 18.80M | 70.50M | 251.60M | 47.90M | 25.90M | 100.80M |
| Unusual income/expense | — | — | — | — | -4.07M | -32.10M | -270.78M | 7.45M | 600.00K | -65.80M | 0 | 0 | 0 | 0 | 200.00K |
| Pretax income | 376.27M | 520.13M | 778.74M | 688.95M | 665.39M | 818.03M | 816.74M | 1.45B | 1.38B | 1.40B | 1.53B | 2.28B | 874.10M | 955.90M | 1.47B |
| Taxes | -128.02M | -170.70M | -210.55M | -227.39M | -230.68M | -300.03M | -388.29M | -517.19M | -529.20M | -520.10M | -393.20M | -515.80M | -242.30M | -264.90M | -546.90M |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 11.79M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.30M | 12.70M | 7.60M |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 248.25M | 349.43M | 568.19M | 461.56M | 446.50M | 518.00M | 428.45M | 932.75M | 851.40M | 884.00M | 1.13B | 1.76B | 644.90M | 707.60M | 915.10M |
| Net income | 248.25M | 349.43M | 568.19M | 461.56M | 446.50M | 518.00M | 428.45M | 932.75M | 851.40M | 884.00M | 1.13B | 1.76B | 644.90M | 707.60M | 915.10M |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 248.25M | 349.43M | 568.19M | 461.56M | 446.50M | 518.00M | 428.45M | 932.75M | 851.40M | 884.00M | 1.13B | 1.76B | 644.90M | 707.60M | 915.10M |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 340.10M | 466.14M | 600.51M | 651.43M | 645.44M | 875.42M | 1.18B | 1.48B | 1.55B | 1.78B | 1.76B | 2.38B | 1.25B | 1.43B | 1.94B |
| EBIT | 327.01M | 445.23M | 567.36M | 587.81M | 516.79M | 693.05M | 998.98M | 1.28B | 1.29B | 1.46B | 1.46B | 2.04B | 865.50M | 958.40M | 1.38B |
| Total operating expenses | -433.64M | -620.69M | -740.15M | -875.00M | -1.23B | -1.62B | -2.04B | -2.28B | -2.74B | -2.89B | -3.49B | -3.84B | -4.40B | -4.76B | -5.49B |
| Prepaid expenses | — | 660.00K | 6.28M | 2.82M | 9.20M | 8.47M | 51.09M | 16.09M | 8.90M | 9.70M | 12.40M | 12.20M | 25.60M | 27.00M | 36.90M |
| Deferred income, current | — | — | — | 18.25M | 12.37M | 21.79M | 26.39M | 32.10M | 45.60M | 306.70M | 358.00M | 93.40M | 60.80M | 61.60M | 136.30M |
| Capital and operating lease obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 54.50M | 54.50M | 157.00M | 118.00M | 118.00M | 169.20M |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | — | — | 720.00K | 6.09M | — | — | 69.38M | 70.63M | 69.50M | 61.90M | 43.90M | 6.00M | 9.80M | 14.30M | 17.90M |
| Deferred income, non-current | 0 | 0 | 0 | 0 | 0 | 3.43M | 200.00K | 90.00K | — | — | — | — | — | — | — |
| Minority interest | 0 | 0 | 0 | 0 | 360.11M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.20M | 8.60M | 3.00M |
| Change in accrued expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | 0 | 0 | 0 | 0 | -228.78M | -449.56M | -485.19M | -638.76M | -323.80M | -1.59B | -528.40M | -793.10M | -793.50M | -952.70M | -953.10M |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
